the aid library

LIST OPTIONS

Filter

2631

AIDSinfo Glossary of HIV/AIDS-Related Terms

AIDSinfo; National Library of Medicine (NIH); Department of Health & Human Services USA AIDSinfo; National Library of Medicine (NIH); Department of Health & Human Services USA (2018) C2

2018 9th Edition Offering information on HIV/AIDS treatment, prevention, and research

Download (577)

View PDF (718)

BCG Vaccine U.S.P. (For percutaneous use)

U.S. Food & Drug Administration; U.S. Department of Health and Human Services (2017) C2

Accessed December 2017

External Link

Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC

Centers for Disease Control and Prevention; Department of health and human services Morbidity and Mortality Weekly Report (2006) C_CDC

Morbidity and Mortality Weekly Report Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9

Download (597)

View PDF (1551)

Drug-Resistant tuberculosis

E.G. Brown Jr, D.S. Dooley, K. Smith Curry International Tuberculosis Center, State of California, California Health & Human Service Agency, Department of Public Health (2016) C1

A survival guide for clinicans. 3rd edition.

Download (401)

View PDF (632)

HIV, HCV, TB and harm reduction in prisons

G. Sander Harm Reduction International; European Union (2016) C1

Human Rights, Minimum Standards and Monitoring at the European and International Levels

Download (160)

View PDF (209)

Building a global atlas of zoonotic viruses

Dennis, C.; B Watso, E.Togami et al. WHO (2018) C_WHO

Despite the human and economic impact of viral epidemics, the world is not well enough prepared for the next emerging viral outbreak. Global trends indicate that new microbial threats will continue to emerge at an accelerating rate, driven by our growing population, expanded travel and trade network... more

External Link

Surveillance, prevention and control of leishmaniases in the European Union and its neighbouring countries

European Centre for disease prevention and control (ECDC) European Centre for disease prevention and control (ECDC) (2022) C_CDC

This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv... more

External Link

Climate-Smart Healthcare : Low-Carbon and Resilience Strategies for the Health Sector

The World Bank Group (2017) CC

Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to climate shifts and least able to adapt given weak health systems and poor infrastructure. Low-carbon appro... more

Download (200)

View PDF (217)

The Global HIV Epidemics among Sex Workers

D. Kerrigan; A. Wirtz; I. Semini; et al. The World Bank (2013) C2

Directions in Development Human Development

Download (241)

View PDF (327)

UNLOCKING RWANDA’S POTENTIAL TO REAP THE DEMOGRAPHIC DIVIDEND

National Institute of Statistics of Rwanda (NISR), the African Institute for Development Policy (AFIDEP) and UNFPA (2017) C2

The Demographic Dividend study on Rwanda assessed the socio-economic and human development potential of our country in the short, medium and long-term period using a comprehensive approach. It generated relevant policy and programme information to guide a well-informed polciy required to propel Rwan... more

Download (273)

View PDF (405)

National Guidelines For Stem Cell Research

Indian Council of Medical Research & Department of Biotechnology (2017) C1

The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells... more

Download (183)

View PDF (177)

National Action Plan for Combating Antimicrobial Resistance In the Hashemite Kingdom of Jordan (2018-2022)

Ministry of Health Jordan (2018) C_WHO

The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.

Download (212)

View PDF (276)

From Research to Action: Advancing Prevention and Response to Violence against Children: Report on the Global Violence against Children Meeting

UNICF (2014)

Growing evidence indicates that large proportions of children around the world experience physical, sexual and emotional violence every year, with enormous implications for human rights, public health and economic and social development.1 Over the last five years, national governments and Together f... more

Download (423)

View PDF (397)

Tanzania: The National Action Plan on AMR 2017-2022

The United Republic of Tanzania - Ministry of Health Community Development Gender Elderly and Children World Health Organization WHO (2017) C_WHO

This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication programmes that targets human, animal and plant... more

Download (153)

View PDF (209)

Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early implementation

World Health Organization WHO (2018) C_WHO

The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re... more

Download (269)

View PDF (312)

Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022

World Health Organization WHO (2022) C_WHO

The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas... more

Download (235)

View PDF (313)

Chagas Disease: Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Clinical Info HIV (2023) CC

Epidemiology Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or... more

External Link

Safe abortion: technical and policy guidance for health systems

World Health Organization (2012)

2nd edition. This new edition provides policy-makers, programme managers and health-service providers with the latest evidence-based guidance on clinical care. It includes information on how to establish and strengthen services, and outlines a human-rights-based approach to laws and policies on safe... more

Download (348)

View PDF (541)

WHO recommendations on adolescent sexual and reproductive health and rights

World Health Organization WHO (2018) C_WHO

This document provides an overview of sexual and reproductive health and rights issues that may be important for the human rights, health and well-being of adolescents (aged 10–19 years) and the relevant World Health Organization (WHO) guidelines on how to address them in an easilyaccessible, user... more

Download (89)

View PDF (82)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more